Literature DB >> 15474031

Interactions of 12-lipoxygenase with phospholipase A2 isoforms following platelet activation through the glycoprotein VI collagen receptor.

Marcus J Coffey1, Barbara Coles, Matthew Locke, Alexandra Bermudez-Fajardo, P Claire Williams, Gavin E Jarvis, Valerie B O'donnell.   

Abstract

Recent studies implicate the collagen receptor, glycoprotein VI (GPVI) in activation of platelet 12-lipoxygenase (p12-LOX). Herein, we show that GPVI-stimulated 12-hydro(peroxy)eicosatetraenoic acid (H(P)ETE) synthesis is inhibited by palmityl trifluromethyl ketone or oleyloxyethylphosphocholine , but not bromoenol lactone, implicating secretory and cytosolic, but not calcium-independent phospholipase A2 (PLA2) isoforms. Also, following GPVI activation, 12-LOX co-immunoprecipitates with both cytosolic and secretory PLA2 (sPLA2). Finally, venoms containing sPLA2 acutely activate p12-LOX in a dose-dependent manner. This study shows that platelet 12-H(P)ETE generation utilizes arachidonate substrate from both c- and sPLA2 and that 12-LOX functionally associates with both PLA2 isoforms. Copyright 2004 Federation of European Biochemical Societies

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15474031     DOI: 10.1016/j.febslet.2004.09.007

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  7 in total

1.  Protease-activated receptor signaling in platelets activates cytosolic phospholipase A2α differently for cyclooxygenase-1 and 12-lipoxygenase catalysis.

Authors:  Michael Holinstat; Olivier Boutaud; Patrick L Apopa; Joanne Vesci; Manju Bala; John A Oates; Heidi E Hamm
Journal:  Arterioscler Thromb Vasc Biol       Date:  2010-12-02       Impact factor: 8.311

2.  Inherited human cPLA(2alpha) deficiency is associated with impaired eicosanoid biosynthesis, small intestinal ulceration, and platelet dysfunction.

Authors:  David H Adler; Joy D Cogan; John A Phillips; Nathalie Schnetz-Boutaud; Ginger L Milne; Tina Iverson; Jeffrey A Stein; David A Brenner; Jason D Morrow; Olivier Boutaud; John A Oates
Journal:  J Clin Invest       Date:  2008-06       Impact factor: 14.808

3.  The enteropathy of prostaglandin deficiency.

Authors:  David H Adler; John A Phillips; Joy D Cogan; Tina M Iverson; Nathalie Schnetz-Boutaud; Jeffrey A Stein; David A Brenner; Ginger L Milne; Jason D Morrow; Oliver Boutaud; John A Oates
Journal:  J Gastroenterol       Date:  2009-01-16       Impact factor: 7.527

4.  Inherited human group IVA cytosolic phospholipase A2 deficiency abolishes platelet, endothelial, and leucocyte eicosanoid generation.

Authors:  Nicholas S Kirkby; Daniel M Reed; Matthew L Edin; Francesca Rauzi; Stefania Mataragka; Ivana Vojnovic; David Bishop-Bailey; Ginger L Milne; Hilary Longhurst; Darryl C Zeldin; Jane A Mitchell; Timothy D Warner
Journal:  FASEB J       Date:  2015-07-16       Impact factor: 5.191

5.  The Impact of Helicobacter pylori Urease upon Platelets and Consequent Contributions to Inflammation.

Authors:  Adriele Scopel-Guerra; Deiber Olivera-Severo; Fernanda Staniscuaski; Augusto F Uberti; Natália Callai-Silva; Natália Jaeger; Bárbara N Porto; Celia R Carlini
Journal:  Front Microbiol       Date:  2017-12-12       Impact factor: 5.640

6.  Phospholipid-esterified eicosanoids are generated in agonist-activated human platelets and enhance tissue factor-dependent thrombin generation.

Authors:  Christopher P Thomas; Lloyd T Morgan; Benjamin H Maskrey; Robert C Murphy; Hartmut Kühn; Stanley L Hazen; Alison H Goodall; Hassan A Hamali; Peter W Collins; Valerie B O'Donnell
Journal:  J Biol Chem       Date:  2010-01-08       Impact factor: 5.157

7.  Helicobacter pylori urease activates blood platelets through a lipoxygenase-mediated pathway.

Authors:  German E Wassermann; Deiber Olivera-Severo; Augusto F Uberti; Célia R Carlini
Journal:  J Cell Mol Med       Date:  2009-09-14       Impact factor: 5.310

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.